PM360

AUGUST 17, 2022

The Trailblazer Awards were established in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. The finalists are in for PM360’s 14 th annual Trailblazer Awards.

Education 105

Education Marketing Pharma Media 105

PharmaTimes

DECEMBER 18, 2023

Scientists recruited 49 volunteers with mild cognitive impairment (MCI) and 45 healthy adults aged 55 years and older who had previously undergone an MRI to measure changes in brain structure and two positron emission tomography (PET) scans of their brains at Johns Hopkins between 2009 and 2022.

Transportation 98

Transportation Medicine Recruitment Patients 98

pharmaphorum

NOVEMBER 6, 2022

3) Biolojic Design : Founded in 2009, the Israeli company uses a structure-based approach, where their model is trained on millions of Antibody-Antigen pairs in order to identify a template antibody against the desired target from existing human antibodies. They have five programs in internal pipeline and partnered programs.

Biopharma 123

Biopharma Pharma Training Leads 123

Medical Device Success

NOVEMBER 17, 2010

Perhaps your company is struggling in the wake of the 2009 economic downturn. This commitment will spread to the employees that aren’t part of the planning team. Employees that see a plan in place will feel more secure about this small company they are working for.

Recruitment 100

Recruitment Sales Media Marketing 100

pharmaphorum

JANUARY 24, 2023

Over the last 25 years, the headcount in the medicines manufacturing sector has fallen by 7,000 and since 2009 production volumes have fallen by nearly a third (29%), suggesting “faltering attractiveness” of the UK for manufacturing. Established trends are unfortunately firmly in the wrong direction.

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

Pharmaceutical Technology

OCTOBER 5, 2022

In 2009, former Biogen employee Michael Bawduniak filed a lawsuit claiming that Biogen had violated the False Claims Act and the Anti-Kickback Statute by providing millions of dollars to healthcare providers (HCPs) as an incentive to prescribe three of its multiple sclerosis (MS) drugs.

Government 59

Government Specialization Physicians Marketing 59

PM360

AUGUST 24, 2023

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. The finalists are in for PM360’s 15 th annual Trailblazer Awards.

Marketing 98

Marketing Education Media Patients 98

pharmaphorum

OCTOBER 19, 2022

Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. Dr Paul Tunnah, chief content officer and managing director UK, Healthware (moderator). The post How the Digital Patient Experience is Shaping the Future of Pharma appeared first on.

Patients 98

Patients Pharma Management Sales technology 98

European Pharmaceutical Review

JANUARY 25, 2024

“Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.” Article 63 EMA (29 January 2020). Key principles for the use of electronic product information for EU medicines” Breinstrup T.

Healthcare 98

Healthcare Healthcare Safety Electronics 98

pharmaphorum

OCTOBER 28, 2022

Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. Dr Paul Tunnah, chief content officer and managing director UK, Healthware (moderator).

Medicine 122

Medicine Management Marketing Leads 122

European Pharmaceutical Review

APRIL 10, 2023

A 2009 study by Eigner et al. On the other hand, the Shimadzu MS showed a high-confidence identification for 639 isolates (88.8 All the high-confidence MS identifications were accurate at the genus level. on 1116 routine isolates representing the main bacterial groups encountered in the clinical microbiology laboratory, showed 95.2

Media 127

Media Healthcare Healthcare Pharmaceutical 127

Pharmaceutical Technology

JULY 29, 2022

Abilify (aripiprazole) , marketed by Bristol Myers Squibb and Otsuka Pharmaceuticals, was approved in 2009 for irritability treatment in six to 17-year-old children with ASD. Generic versions of both drugs are now available.

Side effects 105

Side effects Medical Pharmaceutical Management 105

Med Device Careers

JULY 19, 2021

Since founding PrepMD in 2009, Matt has overseen an organization that has graduated over 500 qualified medical device candidates into the workforce and has expanded business operations to include contract staffing and direct placement services as well as a rapidly expanding cardiac device remote monitoring division.

Medical 52

Medical Training Recruitment Healthcare 52

Clarivate

OCTOBER 31, 2023

It shows an acceleration in published research output, which increased five-fold between 2009 and 2021, well outpacing the U.S. Our latest ISI report, China’s research landscape , draws on Web of Science data to reveal the trajectory and dynamics of China’s research landscape. Our analysis suggests this trajectory is likely to continue.

Engineering 75

Engineering Leads Networking Electronics 75

Salesforce

AUGUST 2, 2022

share-price gain during the 2007-2009 downturn, while the broader stock market declined by 35%, according to an AARP study. share-price gain during the 2007-2009 downturn, while the broader stock market declined by 35%. Inclusive companies (with a diverse workforce across age, gender, race, sexuality, and ability), posted a 14.4%

Training 98

Training Recruitment Marketing Management 98

Pharma Marketing Network

JULY 17, 2023

Along the way, he has worked for the likes of Havas, Cushman & Wakefield and began a deep dive into the healthcare arena in 2009 when he joined Inventiv Health as Head of Digital & innovation. He joined Ogilvy in 2014, as the Chief Digital Officer for Ogilvy CommonHealth, the specialist health care agency within the Ogilvy Group.

Consulting 52

Consulting Education Networking Healthcare 52

pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. In the last 15 years, there has been a noticeable shift towards many prominent players effectively outsourcing innovation to start-ups due to the increasing cost of R&D.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

Pharmaceutical Technology

SEPTEMBER 22, 2022

Since 2009, Meiji has marketed tebipenem HBr in Japan. Under the deal, GSK will obtain an exclusive licence for the development and marketing of tebipenem pivoxil HBr in all countries. This licence will exclude Japan and certain Asian countries, which will be retained by Spero partner Meiji Seika Pharma.

Food and Drug Administration 59

Food and Drug Administration Marketing FDA Media 59

European Pharmaceutical Review

FEBRUARY 22, 2023

Characterization of natural wax esters by MALDI-TOF mass spectrometry, J Mass Spectrom , 2009, 44, 101–110. An overview, J Incl Phenom Macrocycl Chem , 2009, 65, 237-248. Vrkoslav V, Míková R, Cvačka J. Tran A, Monreal IA, et al. 2021, 32, 289–300. Norkus E, Metal ion complexes with native cyclodextrins. Chen Y, Zou Z, Dai X, et al.

Food 98

Food Electronics Pharmaceutical Medical 98

PM360

JANUARY 24, 2025

Airways Flight 1549 in January 2009, when it hit a flock of geese, disabling both its engines. Sometimes the human element can make all the difference. For instance, take the story of Captain Chesley Sully Sullenberger, who was piloting the U.S. 1 The flights systems suggested he should land at LaGuardia or divert to another nearby airport.

Sales 52

Sales Pharma sales reps Patients Prescription 52

pharmaphorum

JANUARY 4, 2023

The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008. According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas’ top products. It is sold as Rapiscan in Europe by GE Healthcare.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

MedReps

OCTOBER 25, 2022

According to a study done back in 2009 , physicians had some interesting things to say about the medical sales representatives they encountered: 87% of those interviewed wanted more clinical studies and fewer glossy brochures. This will help them realize just how useful and well-tested the products are. Why Does Evidence-Based Selling Work?

Medical sales 86

Medical sales Sales Medical Physicians 86

pharmaphorum

JANUARY 3, 2023

ReNeuron was founded in the late 1990s and floated in 2000, but saw slow progress with its stem cell therapies, with approval to start clinical testing arriving in 2009 after the UK cleared a trial of a stroke therapy. Isted joined ReNeuron as chief financial officer in 2021, before stepping up to the top job for just a few months.

Biopharma 59

Biopharma Pharma Leads Management 59

European Pharmaceutical Review

DECEMBER 5, 2024

Aulton’s Pharmaceutics: The Design and Manufacture of Medicines (5th ed.). Lachman L, Lieberman H A, Kanig J L. The Theory and Practice of Industrial Pharmacy (4th ed.). CBS Publishers & Distributors. Rowe R C, Sheskey P J, Quinn M E. Handbook of Pharmaceutical Excipients (6th ed.). Pharmaceutical Press.

Pharmaceutical 52

Pharmaceutical Manufacturing Leads Medicine 52

pharmaphorum

SEPTEMBER 26, 2022

Lexiscan was originally developed by CV Therapeutics, which licensed rights to the drug to Astellas shortly before the Japanese pharma launched a hostile bid for the company – thwarted when it was acquired by Gilead in 2009. The post Astellas facing generics to big-selling Lexiscan product in US appeared first on.

Pharmacology 52

Pharmacology FDA Marketing Pharma 52

European Pharmaceutical Review

SEPTEMBER 14, 2023

In 2001 and 2007, through 2009, the economy was hit hard. As a result of the economic uncertainty, 75 percent of life sciences company executives have experienced negative impacts on their business in the current macroeconomic climate. 1 We can only learn from the past and try not to repeat history.

Manufacturing 98

Manufacturing Management Engineering Pharmaceutical 98

pharmaphorum

JUNE 28, 2022

Ceftobiprole was turned down by the FDA in 2009 for ABSSSI, when the drug was partnered with Johnson & Johnson’s Janssen Cilag unit. If it gets a green light, it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S.

Side effects 52

Side effects FDA Marketing Government 52

Pharmaceutical Technology

APRIL 12, 2023

Since the inception of the ACA, changes in cancer screening among privately insured individuals show an overall increase in colorectal cancer screening tests.

Insurance 52

Insurance Leads Medical 52

Nixon Gwilt Law

FEBRUARY 27, 2023

Notably, this rulemaking does not propose to implement the “special registration” for telemedicine providers the DEA has been promising since the Ryan Haight Act passed in 2009. Instead, it would create a new regulatory category of the “practice of telemedicine.”

Prescription 105

Prescription Medical Patients Specialization 105

pharmaphorum

AUGUST 24, 2022

A federal judge has ruled that a jury trial will be needed to resolve allegations that Indivior attempted to preserve a monopoly by switching to a sublingual film formulation of Suboxone (buprenorphine/naloxone) in 2009 from an older pill version of the product.

Marketing 52

Marketing Competition Healthcare Healthcare 52

pharmaphorum

SEPTEMBER 27, 2022

The suit claimed that Biogen paid millions of dollars to doctors in the form of speaker honoraria, training fees, consulting fees, and meals to induce them to prescribe the MS drugs Avonex (interferon-beta-1a), Tysabri (natalizumab), and Tecfidera (dimethyl fumarate) between 2009 and 2014.

Government 45

Government Doctors Consulting Training 45

pharmaphorum

OCTOBER 13, 2022

Mr. Baxter joined VBI in September of 2009. Stern School of Business at New York University and a Bachelor of Sciences in Supply Chain Management from the Martin J. Whitman School of Management at Syracuse University. Jeff Baxter – President and CEO, VBI Vaccines.

Management 52

Management Pharma Consulting Leads 52

pharmaphorum

JULY 5, 2022

Prior to this, he founded the industry-leading publication, pharmaphorum, in 2009, which also provides broader content communications and marketing services to enable more effective customer engagement.

Patients 98

Patients Medicine Marketing Recruitment 98

European Pharmaceutical Review

AUGUST 24, 2023

[EY analysis showed] companies with a greater therapeutic area focus had greater return on capital over five years, compared to companies with greater diversification” Between 2000 to 2009, the predominant pharmaceutical company strategy was the creation of large portfolios spanning multiple categories through mega-mergers.

Biopharma 98

Biopharma Pharmaceutical Pharma Medical 98

Clarivate

NOVEMBER 10, 2022

The evidence standards that a COA must meet to support key clinical trial endpoints have become increasingly stringent in recent decades, following the introduction of the United States Food and Drug Administration (FDA) Patient Reported Outcomes (PRO) draft guidance in 2006, followed by the full guidance in 2009.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Nixon Gwilt Law

JUNE 10, 2024

Multi-Million-Dollar Penalties and the Evolution of the HBNR The HBNR was first implemented by the FTC [CN2] in 2009 to advance the use of health information technology while strengthening privacy and security protections for health information not covered by HIPAA. Beginning in 2021, this long-held position began to change.

Electronics 52

Electronics Healthcare Healthcare Medical 52

Nixon Gwilt Law

JUNE 10, 2024

Multi-Million-Dollar Penalties and the Evolution of the HBNR The HBNR was first implemented by the FTC [CN2] in 2009 to advance the use of health information technology while strengthening privacy and security protections for health information not covered by HIPAA. Beginning in 2021, this long-held position began to change.

Electronics 52

Electronics Healthcare Healthcare Medical 52